Sponsor:
The POLG Foundation
Code:
NCT07775872
Conditions
PolG, Primary Mitochondrial Myopathy
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
PolG, Primary Mitochondrial Myopathy
Study ID
NCT07775872
Start date
Jun 17, 2026
Status verified date
Nov, 2026
Completion date
Jun 17, 2031
Anticipated
Primary completion date
Jun 17, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Enrollment
200 participants
Anticipated
Arms
Single Observational Cohort
Primary outcome measure
Central contacts
Locations
Akron Children's Hospital
Recruiting
Akron, Ohio, United States, 44308
Contacts
Principal Investigator:
Bruce Cohen
Children's Hospital of Philadelphia-Philadelphia
Recruiting
Philadelphia, Pennsylvania, United States, 19104
Contacts
UTHealth Houston
Recruiting
Houston, Texas, United States, 77030
Contacts
Principal Investigator:
Mary Kay Koeing
Sponsor
The POLG Foundation
Last update posted
Nov 18, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by The POLG Foundation on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.